The amendments to the indenture governing the 2018 Notes contained in the supplemental indenture, dated as of June 21, 2013 (the “Consent Date”), became operative upon today’s acceptance of the tendered 2018 Notes by the Company pursuant to the terms and conditions described in the Offer to Purchase. 2018 Notes not tendered and purchased pursuant to the tender offer will remain outstanding, and the holders thereof will be bound by the amendments contained in the supplemental indenture even though they have not consented to such amendments.Subject to the terms and conditions set forth in the Offer to Purchase, holders who validly tendered their 2018 Notes on or prior to the Consent Date will receive the total consideration of $1,117.50 per $1,000 principal amount of 2018 Notes accepted for purchase, which includes a consent payment of $30.00 per $1,000 principal amount of 2018 Notes. Holders who validly tendered their 2018 Notes after the Consent Date but on or prior to Expiration Date will receive the tender offer consideration of $1,087.50 per $1,000 principal amount of 2018 Notes accepted for purchase. Holders of 2018 Notes tendered after the Consent Date will not receive the consent payment. In addition, holders of all 2018 Notes accepted for purchase by the Company will receive accrued and unpaid interest up to, but not including, July 23, 2013. Citigroup Global Markets Inc. acted as the dealer manager and solicitation agent and D.F. King & Co., Inc. acted as the tender agent and information agent for the tender offer and consent solicitation. Requests for documents may be directed to D.F. King & Co., Inc. at (800) 829-6551 (toll-free) or (212) 269-5550 (collect). Questions regarding the tender offer and consent solicitation may be directed to Citigroup Global Markets Inc. at (800) 558-3745 (toll-free) or (212) 723-6106 (collect). This press release is for informational purposes only and does not constitute an offer to buy or a solicitation of an offer to sell or a solicitation of consents with respect to any securities, and should not be deemed to be an offer to sell or a solicitation of an offer to buy any securities of the Company. The Notes offering was made only by means of a written prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended, and was not made to any person in any jurisdiction in which the offer, solicitation or sale would be unlawful. The tender offer and consent solicitation were made only pursuant to the terms of the Offer to Purchase and were not made in any jurisdiction in which the making or acceptance thereof would not be in compliance with the securities, blue sky or other laws of such jurisdiction.
About Chemtura CorporationChemtura, with 2012 net sales of $2.6 billion, 1 is a global manufacturer and marketer of specialty chemicals, agrochemicals and pool, spa and home care products. 1 2012 net sales of $2.6 billion reflects discontinued operations treatment for the sale of Chemtura’s Antioxidants business.